THE MARTINIQUE PRINCIPLES IN RADIOIODINE THERAPY OF DIFFERENTIATED THYROID CANCER

The latest recommendations of the American Thyroid Association have caused serious disagreements between the  nuclear medicine and endocrinologist communities regarding the radioactive iodine use. In 2018 eighteen experts  from 8 countries and 4 leading organizations (ATA, EANM, SNMMI and ETA) met for the first time to establish mutual understanding in the role of radioiodine therapy for differentiated thyroid cancer. After much discussion and exchange of experience, the participants developed a consensus document based on the so-called nine principles of  Martinique. We present an overview of the article published 2019 in Thyroid, entitled «Controversies, consensus, and collaboration in the use of 131 I therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association».